Scarica l'app Stockscreener
17.77
5.71%
0.96
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie
ClearPoint Neuro (CLPT) surges 26.0%: Is this an indication of further gains? - MSN
Liquidity Mapping Around (CLPT) Price Events - Stock Traders Daily
CLPT Maintained by B. Riley Securities -- Price Target Raised to $30 - GuruFocus
Clearpoint Neuro Inc (CLPT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ClearPoint Neuro: AMT-130's FDA Reversal Revives The Bull Case (NASDAQ:CLPT) - Seeking Alpha
B. Riley Adjusts ClearPoint Neuro Price Target to $30 From $20, Maintains Buy Rating - marketscreener.com
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains? - Yahoo Finance
Clearpoint Neuro Inc (CLPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clearpoint Neuro Inc (CLPT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Clearpoint Neuro Inc (CLPT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clearpoint Neuro Inc (CLPT) Institutional Confidence - TradingKey
Clearpoint Neuro Inc (CLPT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Clearpoint Neuro Inc (CLPT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Clearpoint Neuro Inc (CLPT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
[144] ClearPoint Neuro, Inc. SEC Filing - Stock Titan
ClearPoint Neuro (CLPT) Sees Significant Pre-Market Gains Following Partner Announcement - GuruFocus
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
ClearPoint Neuro Shares Jump as FDA Progress for UniQure Therapy Highlights Platform Value - Yahoo Finance
$ClearPoint Neuro (CLPT.US)$ LG…time to see some better DDs…🏎👍🏿🔥🔥🔥🔥🔥🏁 - Moomoo
$ClearPoint Neuro (CLPT.US)$ small bag for a small pop over $20 - Moomoo
ClearPoint Neuro Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesShort-Term Outlook - newsline.com
Analysts Offer Insights on Healthcare Companies: Artivion (AORT), Incyte (INCY) and ClearPoint Neuro (CLPT) - The Globe and Mail
Stifel reiterates Clearpoint Neuro stock rating on neurosurgery platform By Investing.com - Investing.com South Africa
Stifel reiterates Clearpoint Neuro stock rating on neurosurgery platform - Investing.com
Stifel Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $16 - Moomoo
ClearPoint Neuro (CLPT) director exercises options and withholds shares for taxes - Stock Titan
Why (CLPT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - ACCESS Newswire
Director at ClearPoint Neuro (NASDAQ: CLPT) sells shares to cover taxes - Stock Titan
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - Moomoo
CLPT: Director compensation shares (5,145) to be sold via Form 144 (06/01/2026) - Stock Titan
ClearPoint Neuro, Inc.: ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - FinanzNachrichten.de
Director Of ClearPoint Neuro Sold 25% Of Their Shares - simplywall.st
ClearPoint Neuro plans entry into focused ultrasound market - Investing.com UK
ClearPoint Neuro plans entry into focused ultrasound market By Investing.com - Investing.com Nigeria
Understanding Momentum Shifts in (CLPT) - Stock Traders Daily
Brain ultrasound deal tests drug delivery across blood-brain barrier - Stock Titan
How The ClearPoint Neuro (CLPT) Narrative Is Shifting On Partnerships Valuation And FDA Risks - Yahoo Finance
ClearPoint Neuro (CLPT) director receives grant of 12,820 RSUs - Stock Titan
ClearPoint Neuro (CLPT) director receives 12,820 restricted stock units in equity grant - Stock Titan
[Form 4] ClearPoint Neuro, Inc. Insider Trading Activity - Stock Titan
Director at ClearPoint Neuro (CLPT) receives 12,820 restricted stock units - Stock Titan
Director at ClearPoint Neuro (NASDAQ: CLPT) awarded 12,820 RSUs - Stock Titan
Director at ClearPoint Neuro (CLPT) receives 12,820 restricted stock units grant - Stock Titan
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Director FALLON LYNNETTE C - Moomoo
CLPT Q1 2026 Earnings: EPS Misses Estimates as Revenue Details Remain UndisclosedAnnual Financial Report - newsline.com
ClearPoint Neuro Shareholders Approve Incentive Plan and Directors - The Globe and Mail
ClearPoint Neuro Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock MovementPre-Earnings Setup - newsline.com
Director Matthew Klein of ClearPoint Neuro (CLPT) receives 12,417 shares from RSU vesting - Stock Titan
Tax sale by ClearPoint (CLPT) director after RSU vesting - Stock Titan
Director at ClearPoint Neuro (NASDAQ: CLPT) gains 12,417 shares via RSU vesting - Stock Titan
ClearPoint Neuro (CLPT) investors approve directors, pay and updated incentive plan - Stock Titan
ClearPoint Neuro (CLPT) director converts 12,417 RSUs into common shares - Stock Titan
ClearPoint Neuro (CLPT) director settles 12,417 RSUs into common stock - Stock Titan
Director Pascal Girin converts 12,417 RSUs into ClearPoint Neuro (CLPT) common shares - Stock Titan
ClearPoint Neuro (CLPT) director converts 12,417 RSUs into common stock holdings - Stock Titan
16,000-share sale by CLPT (NASDAQ: CLPT) from vested restricted plan - Stock Titan
ClearPoint Neuro Earnings Call Signals Growth With Strain - TipRanks
Compared to estimates, ClearPoint Neuro (CLPT) Q1 earnings: A look at key metrics - MSN
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):